RxRevu has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RxRevu is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kyle Kiser played a key role in securing…
